Comparison of Posttherapy 4- and 24-Hour [177Lu]Lu-PSMA SPECT/CT and Pretherapy PSMA PET/CT in Assessment of Disease in Men with Metastatic Castration-Resistant Prostate Cancer

前列腺癌 医学 核医学 放射科 癌症 内科学
作者
Mina Swiha,Sarennya Pathmanandavel,Nathan Papa,Zahra Sabahi,Sherrington Li,Alex Zheng,Sobia Khan,Maria Ayers,Shikha Sharma,Megan Crumbaker,Andrew Nguyen,Lyn Chan,Narjess Ayati,Louise Emmett
出处
期刊:The Journal of Nuclear Medicine [Society of Nuclear Medicine]
卷期号:: jnumed.124.267606-jnumed.124.267606
标识
DOI:10.2967/jnumed.124.267606
摘要

[177Lu]Lu-prostate-specific membrane antigen (PSMA) is an effective treatment for metastatic castration-resistant prostate cancer (mCRPC). [177Lu]Lu-PSMA SPECT/CT 24 h after injection has shown potential as a response biomarker for [177Lu]Lu-PSMA therapy but is not convenient for patients. This study investigated 4-h [177Lu]Lu-PSMA SPECT/CT as an alternative to 24-h [177Lu]Lu-PSMA SPECT/CT for evaluation of treatment response. Methods: This prospective analysis enrolled 23 patients diagnosed with mCRPC commencing [177Lu]Lu-PSMA-I&T therapy. Two patients were excluded because of incomplete imaging data. Posttherapy SPECT/CT was performed at 4 and 24 h after the first dose and 4 h after the second dose. Baseline [68Ga]Ga-PSMA-11 PET/CT and 4- and 24-h [177Lu]Lu-PSMA SPECT/CT were analyzed both visually and semiquantitatively. Bland–Altman plots assessed agreement of semiquantitative parameters from the 4- and 24-h scans. Quantitative assessment of the change in the total tumor volume (TTV) on the 4-h [177Lu]Lu-PSMA SPECT/CT after the first and second doses was correlated to patient outcomes. Results: All patients had mCRPC previously treated with an androgen receptor pathway inhibitor, and 11 (52%) received prior taxane chemotherapy. Median age was 78 y, and median prostate-specific antigen level was 54 ng/mL. On visual analysis, disease distribution was unchanged among the 3 imaging methods. Eleven patients (52%) had a median of 1 lesion not identified on 4-h [177Lu]Lu-PSMA SPECT/CT compared with 24-h [177Lu]Lu-PSMA SPECT/CT. All missed lesions on the 4-h [177Lu]Lu SPECT/CT were smaller than 2 cm. Mean differences and agreement between 4- and 24-h SPECT/CT quantitative parameters were within acceptable bounds for lesion number, SUVmax, and SUVmean, with higher variation observed for TTV. The change in TTV between dose 1 and 2 [177Lu]Lu-PSMA SPECT/CT predicted prostate-specific antigen progression-free survival. Conclusion: [177Lu]Lu-PSMA SPECT/CT at 4 h after injection appears a promising alternative to 24-h [177Lu]Lu-PSMA SPECT/CT for treatment response assessment, with improved patient convenience.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
科研通AI2S应助xh采纳,获得10
刚刚
苏靖完成签到,获得积分10
1秒前
1秒前
yogurt发布了新的文献求助10
1秒前
陈早睡完成签到,获得积分10
1秒前
LL发布了新的文献求助10
1秒前
山猫完成签到,获得积分10
1秒前
辛勤晓蓝发布了新的文献求助10
2秒前
慕青应助Charlse_Su采纳,获得20
2秒前
2秒前
合适冬云完成签到,获得积分10
2秒前
汉堡包应助高兴翠绿采纳,获得10
2秒前
yyc666完成签到,获得积分20
3秒前
Gorden发布了新的文献求助10
4秒前
香蕉剑鬼完成签到,获得积分10
4秒前
千万完成签到,获得积分10
4秒前
5秒前
5秒前
yyc666发布了新的文献求助10
6秒前
6秒前
6秒前
7秒前
炙热的凌寒完成签到 ,获得积分20
7秒前
prolooklog发布了新的文献求助10
8秒前
star009完成签到,获得积分10
8秒前
8秒前
水水发布了新的文献求助10
9秒前
苗苗043发布了新的文献求助20
9秒前
小马甲应助苏安莲采纳,获得10
9秒前
高高秋发布了新的文献求助10
9秒前
9秒前
qqqyy发布了新的文献求助10
10秒前
10秒前
10秒前
Singularity应助烦烦烦方法采纳,获得10
10秒前
11秒前
大个应助懒羊羊采纳,获得20
11秒前
11秒前
深情安青应助宸哥采纳,获得10
11秒前
高分求助中
The ACS Guide to Scholarly Communication 1000
Handbook of the Mammals of the World – Volume 3: Primates 805
Ethnicities: Media, Health, and Coping 800
Gerard de Lairesse : an artist between stage and studio 500
Digging and Dealing in Eighteenth-Century Rome 500
Queer Politics in Times of New Authoritarianisms: Popular Culture in South Asia 500
Manual of Sewer Condition Classification 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3069341
求助须知:如何正确求助?哪些是违规求助? 2723227
关于积分的说明 7480825
捐赠科研通 2370161
什么是DOI,文献DOI怎么找? 1256872
科研通“疑难数据库(出版商)”最低求助积分说明 609730
版权声明 596852